Nephrocheck预测心脏术后院内急性肾损伤及主要不良肾脏事件
该研究纳入610例非急诊体外循环心脏手术患者,评估术后6小时Nephrocheck AKI风险评分与院内AKI及5年内MAKE的关联。结果显示6小时评分与AKI显著相关,峰值评分与MAKE呈非线性关联,高阈值组MAKE风险更高。
要点
- 6小时Nephrocheck阈值>0.14与院内AKI风险增加约2.3倍相关。
- 术后峰值Nephrocheck>1.69与5年内MAKE风险增加约1.75-2.04倍相关。
核心结论
- 体外循环后6小时Nephrocheck AKI风险评分与心脏术后院内AKI显著相关。
- 术后峰值Nephrocheck测量值与心脏术后5年内MAKE显著相关,且呈非线性关联。
研究设计与样本
- 研究纳入610例接受非急诊体外循环心脏手术的患者。
- 评估体外循环后6小时Nephrocheck AKI风险评分与AKI的关联。
- 评估体外循环后6小时至术后第4天峰值Nephrocheck评分与MAKE的关联。
- NephroCheck值经log2转换并均值中心化,采用逻辑回归和Cox回归分析。
- 通过ROC分析和约登指数确定最佳阈值。
主要发现
- 术后全阶段院内AKI发生率为110/610(18.0%),MAKE发生率为257/610(42.1%)。
- 6小时生物标志物浓度每翻倍,未调整模型AKI的OR为1.49(95%CI 1.27-1.75,P<.001),调整模型OR范围为1.39-1.42(P<.001)。
- ROC-derived阈值>0.14与AKI风险增高相关,未调整OR为2.43(95%CI 1.60-3.69,P<.001),调整模型OR范围为2.28-2.34(P<.001)。
- MAKE呈非线性关联:二次项在未调整模型HR为1.09(95%CI 1.04-1.13,P<.001),调整模型HR范围为1.06-1.07(P<.008)。
- 峰值Nephrocheck>1.69单位的患者MAKE风险更高,未调整HR为2.11(95%CI 1.55-2.85,P<.001),调整模型HR范围为1.75-2.04(P<.001)。
关键数值与推荐
- 6小时Nephrocheck AKI风险评分阈值>0.14与院内AKI风险增高相关(调整OR 2.28-2.34)。
- 峰值Nephrocheck AKI风险评分>1.69单位与MAKE风险增高相关(调整HR 1.75-2.04)。
临床怎么用
- 心脏手术后6小时可检测Nephrocheck AKI风险评分以辅助识别院内AKI高风险患者。
- 术后动态监测Nephrocheck峰值有助于评估5年内MAKE风险,高峰值患者需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute kidney injury (AKI) is a common complication after cardiac surgery and is a risk factor for long-term major adverse kidney events (MAKE). This study aimed to evaluate the association between postoperative Nephrocheck AKI risk score with postoperative in-hospital AKI and MAKE up to 5 years after cardiac surgery. METHODS: The study included 610 patients who underwent nonemergent cardiac surgery with cardiopulmonary bypass (CPB). The Nephrocheck AKI risk score 6 hours after CPB was evaluated for association with AKI. The peak Nephrocheck AKI risk score that occurred between 6 hours post-CPB and postoperative day 4 was evaluated for association with MAKE. NephroCheck values were log2-transformed and mean-centered. Logistic and Cox regression were used to assess associations with AKI and MAKE, respectively. Models included linear terms and quadratic and cubic terms to evaluate nonlinearity. Optimal thresholds were derived using receiver operating characteristic (ROC) analysis and the Youden index. RESULTS: The incidence of postoperative all-stage in-hospital AKI was 110/610 (18.0%), and the incidence of MAKE was 257/610 (42.1%). For AKI, higher-order terms were not significant; therefore, linear models were retained. Each twofold increase in the 6-hour biomarker concentration was associated with increased odds of AKI in unadjusted (OR 1.49; 95% confidence interval [CI], 1.27-1.75; P < .001) and adjusted models (OR range 1.39-1.42; P < .001). An ROC-derived threshold >0.14 was associated with higher odds of AKI in unadjusted (OR 2.43; 95% CI, 1.60-3.69; P < .001) and adjusted models (OR range 2.28-2.34; P < .001). For MAKE, a nonlinear association was observed. The linear term was not significant, whereas the quadratic term was significant in both unadjusted (HR 1.09; 95% CI, 1.04-1.13; P < .001) and adjusted models (HR range 1.06-1.07; P < .008), indicating that the risk of MAKE increases disproportionately at higher peak NephroCheck concentrations. The cubic term was not significant. Patients with peak Nephrocheck AKI risk score >1.69 units had a higher risk of MAKE in unadjusted (HR 2.11; 95% CI, 1.55-2.85; P < .001) and adjusted models (HR range 1.75-2.04; P < .001). CONCLUSIONS: Nephrocheck AKI risk score 6 hours post-CPB was significantly associated with in-hospital postoperative AKI. Peak postoperative NephroCheck measurements were also significantly associated with MAKE up to 5 years after cardiac surgery.
引用
- Cheruku SR, Neyra JA, Trinh J, et al. Nephrocheck for Prediction of In-Hospital Acute Kidney Injury and Major Adverse Kidney Events After Cardiac Surgery. Anesth Analg. 2026. PMID: 42085354. doi:10.1213/ANE.0000000000008079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。